Logo Investing Whisperer
Logo HomeInvesting Whisperer

Our best picks right to your inbox.

Our insights. Your Success.

Subscribe Today!
  • Home
  • Subscriber Benefits
  • Portfolio
  • Why Us?
  • Login
Subscribe Today!
  • Home
  • Subscriber Benefits
  • Portfolio
  • Why Us?
  • Login
Subscribe Today!

Articles

See All
IN THE MONEY ADVANCED MICRO DEVICES

IN THE MONEY ADVANCED MICRO DEVICES

1

The Trade

Buy AMD shares, sell June $150.00 calls against the long position

2

3

Extended Commentary

Our May covered call trade involves buying AMD shares at $167.39 and writing June 21st, $150.00 calls for $20.25. The covered call trade should generate a 1.71% return if AMD shares trade at $150.00 (or above) at the options expiration – a 17.67% annualized return. The trade breaks even if AMD trades down to $147.14 – a full $20.25 per share (12.10%) below the current price.

4

5

6

7

Company Overview

Advanced Micro Devices is a U.S. based semiconductor company which produces high-performance processors, graphics cards, and related technologies for consumer, enterprise, and data center markets. In addition, AMD has recently introduced the MI300 GPU, a datacenter powerhouse which sells for $12,000 versus NVIDIA’s $32,000 H100 despite similar performance. AMD’s product portfolio includes Ryzen processors for desktops and laptops, Radeon graphics cards, and EPYC server processors. AMD has been gaining significant market share in their CPU segment as Intel stumbled with their latest generation of CPUs. Windows 12 is expected to be announced in June and will shift AI workloads away from cloud and data centers to local PCs.

Potential Newsflow

Windows 12, which will require consumers (particularly business consumers) to purchase new PCs is expected to be announced in June for an October release.

Market Exposure/Risk of a 10% Change in Equity Prices (S&P 500)

With a beta of 1.31, we would expect AMD shares to decline 13.1% if the S&P 500 declined 10.0%, sending the shares to $145.46. This would result in an anticipated loss of $1.68 on the covered call position at expiration. If the S&P 500 rallied 10.0%, AMD shares would likely rally 13.1% (to $189.32) the covered call trade would realize the maximum gain of $2.86 per share, or 1.71%.

It was a big news day for AMD, though most of the headlines weren’t picked up in news feeds. First, Elon Musk’s AI startup – xAI – was reported to have chosen Oracle (cloud) and AMD (GPUs) for their new datacenters to be built with the $6 bln they just raised. I would guess AMD’s resulting revenue would amount to roughly $600 mln to $1,200 mln based on the likely number of GPUs to purchase. The purchase could be a vote of confidence in AMD, or it could be the result of AMD being the only available GPU for 2024 and early 2025 delivery and/or the fact that AMD is 1/3 the price of NVIDIA. If we knew the planned startup that would help (If it’s in late 2025 or 2026 then NVIDIA would have been in play). Either way, it’s a nice contract for AMD.

Second, in a major blow to NVIDIA, Samsung did not pass NVIDIA’s testing for the latest-and-greatest HBM3e memory for GPUs (link). NVIDIA is really pushing the envelope with their new ‘Blackwell’ GPUs – which I still believe is a minor upgrade to the H100 which relies on memory and a CPU to speed it up rather than an improved GPU – and I’m guessing the heat generation of Samsung’s memory was too high for NVIDIAs hardware which crams in two GPUs and a CPU on one (albeit large) card. This leaves NVIDIA with only Micron as a supplier, and this will limit production of the Blackwell GPU through 2025. It also frees up memory for AMD to use and memory (plus GPU assembly) is the primary constraint to total industry GPU production through 2025.

Third, HSBC wrote (I don’t have the full note) that NVIDIA’s new GB200 GPU (with two GPUs and a CPU on board) will cost $60,000 to $70,000 – countering the common perception that it will cost $30,000. Jim Cramer started the $30,000 fixation when he asked NVIDIA CEO Jensen Huang how much it would cost and Huang held up one single GPU processor and said ‘this costs $30,000.’

I swear there isn’t usually daily news on AMD, but Ilya Sutskever, cofounder and chief scientist at OpenAI (and arguably the brains behind the operation) as well as Jan Leike, head of the ‘Superalignement Team’ (the team dedicated to preventing rogue AI behaviors at OpenAI) have left the company. Both announced their resignations on Twitter (or X, which still sounds dumb to me):

8

9

There are more than a few posts online that a large wave of key employees are following them out the door and they are all going to… xAI – Musk’s startup. I would say announcing the departures on Twitter adds some weight to the rumor – but realistically there is no other place to go (besides starting a new firm).

With $6 bln in hand and some of the best AI minds in the business on board, it now looks like xAI will be able to raise A LOT of money (OpenAI is valued at $80 bln) – and it sounds like xAI will be an all-AMD hardware company. If xAI is truly going to compete with OpenAI, Meta and Google, they need 500,000 NVIDIA H100 equivalent GPUs, or about $6 bln worth at $12,000 per GPU (Meta will have 600,000 at year end, OpenAI may have 700,000). Keep in mind just over half of the processing power at OpenAI is utilized to run the model and serve up user requests, so any company planning equal popularity needs to plan on 200,000 to 400,000 GPUs for running the model – or inferencing – a year or so out.

Not only does xAI look like a big AMD customer, but having a major LLM developer move to all-AMD hardware means a lot of focus will come to developing new software tools for AMD, obviously making their GPUs more appealing (AI developers opensource their software tools and work on them collaboratively…) In NVIDIAs case, the output of the A100 GPU more than doubled over the two years following the release due to optimized software).

Special Offer: For a limited time, get all our new In The Money trades, for free, direct to your mailbox. Click Here

YOU MAY ALSO BE INTERESTED IN:
  • AKERO THERAPEUTICS (AKRO – NASDAQ) THE ONLY COMPANY TO REVERSE LATE STAGE LIVER DISEASE WHAT’S THAT WORTH?
  • THIS STOCK IS DEPRESSED DESPITE POSTING BEST DATA EVER GH RESEARCH (GHRS – NASDAQ)
  • HELIOSTAR (HSTR – TSXv / HSTXF-OTC) AND MAKO MINING (MKO – TSXv)BOUGHT CHEAP AND SEE THEM NOW!

A smart investor's advantage to finding next big win is research and the ability to cut through the noise.

Let Investing Whisperer be your advantage

Subscribe Today!
Logo
  • Privacy Policy
  • Terms and Conditions
  • Contact

© 2025 Investing Whisperer! All Rights Reserved.

link

By clicking on 'Accept' you are consenting to the use of performance and functional cookies, designed to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Performance cookies

These cookies allow us to count visits and traffic so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Functional cookies

These cookies enable our website to provide enhanced functionality and personalisation. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, then some or all of these services may not function properly.

These cookies are set by the function provided but hosted by Investing Whisperer.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy